Contract testing service for screening candidate compounds of pharmaceuticals in the research and development stage from the perspectives of drug discovery and safety pharmacology.
We offer contract testing services to screen candidate compounds for pharmaceuticals in the research and development stage using Sophion's automated patch clamp systems, Qube and QPatchII, from the perspectives of drug discovery and safety pharmacology. By combining the reliability and throughput of QPatch and Qube, we can provide high-quality data quickly. Additionally, it is possible for you to provide your own cells for testing. If you are planning screening tests targeting ion channels, please feel free to consult with us. ■ Ion channels available for testing at any time: hERG ■ QPatch, with a proven track record across various ion channels, provides reliable and high-quality data. *For more details, please download the PDF or feel free to contact us.
Inquire About This Product
basic information
For more details, please download the PDF or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Sophion Bioscience was founded by a passionate group of electrophysiologists with a common goal of providing objective patch clamp results quickly and accurately, independent of the experimenter's skill. We have grown from a small startup in Denmark to a global company, but our passion and commitment to providing high-performance patch clamp solutions remain unchanged. Through exceptional technical service and application support, we back our customers in achieving their goals. Additionally, with the continuous development of the QPatch and Qube platforms, we ensure uncompromising data quality in a user-friendly environment, from assay setup to data analysis.
